Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Wyeth presents new estrogenic agents with potential in menopause, endometriosis, etc.

Oct. 15, 2003

Selective progesterone receptor modulators prepared and tested at Schering AG

Oct. 15, 2003

Spotlight on PPAR agonists in development for diabetes mellitus

Oct. 15, 2003

Spotlight on contraceptive research

Oct. 15, 2003

New therapeutic target for type 2 diabetes: beta-cell apoptosis

Oct. 15, 2003

Approval for prefilled syringe presentation of Ovidrel

Oct. 14, 2003

Estrasorb approved for reduction of vasomotor symptoms in menopausal women

Oct. 14, 2003

New DPP-IV inhibitors covered by Sanofi-Synthelabo patent

Oct. 14, 2003

PPAR modulators and their use presented in recent patents

Oct. 13, 2003

Dosing completed in TOP study of Preos

Oct. 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...